Superior Profit
This biotech stock is looking weak. 

Stock breaking below Memory support lines. Weekly flipped to bearish color from bullish color one week ago. Today it is down with high Pressure as seen from CUE Scorecard. MRTX is overvalued and has negative earnings growth in the latest quarter. The biotech industry is strong as per Scorecard. However, it is not uncommon for Biotech stocks to move based on its own strength/weakness and not rely that much on industry's move.

Long position holders may be cautious. There is no low-risk CUE short entry setup right now. One may add it to watchlist and look for such entry. One may use Fine-Tune chart to look for such entry in coming days if one is fine with using intraday charts for trade entry.

Snapshots as of ~3:40 PM EST.


mrtx chart 2018-09-26_15-37-40.jpg  MRTX edge 2018-09-26_15-42-30.jpg  MRTX pressure 2018-09-26_15-38-42.jpg  MRTX vital 2018-09-26_15-41-23.jpg 
0 0
Superior Profit
Since the post (point 1), MRTX indeed fell more. Only low-risk entry could be made on the point 1 day using real-time Fine Tune chart. At the right edge (point 2), the stock is hitting white Direction Line support and CUE traders, if they could take the long, would book profit.



MRTX exit 2018-10-12_9-07-05.jpg 
0 0